An AVM (arteriovenous malformation) is not a stroke itself, but it is one of the main causes of hemorrhagic stroke. The American Stroke Association lists AVMs alongside aneurysms as the two types of weakened blood vessels that most commonly cause bleeding in the brain. So while having an AVM doesn’t mean you’ve had a stroke, it does mean you carry an ongoing risk of one.
What an AVM Actually Is
An arteriovenous malformation is a tangle of abnormal blood vessels in the brain where arteries connect directly to veins, bypassing the normal network of tiny capillaries in between. Capillaries slow blood flow and allow oxygen to transfer into brain tissue. Without them, high-pressure arterial blood rushes straight into veins that aren’t built to handle it. Over time, this pressure weakens the vessel walls.
AVMs are present from birth, though most people don’t know they have one until symptoms appear. The average age at diagnosis is about 31, which makes AVM-related strokes far more common in younger adults than the typical strokes caused by blocked arteries, which tend to strike people over 65.
How an AVM Causes a Stroke
When the weakened vessels in an AVM rupture, blood leaks into the brain or surrounding tissues. This is a hemorrhagic stroke. The bleeding damages brain cells directly, increases pressure inside the skull, and reduces blood flow to nearby areas. The effects depend on where the AVM is located and how much blood escapes.
AVMs can also cause stroke-like symptoms without rupturing. In what’s known as the “steal” effect, the malformation diverts blood away from healthy brain tissue. Because blood takes a shortcut through the AVM instead of flowing through normal capillaries, surrounding areas can be starved of oxygen. This can produce neurological symptoms that mimic a stroke, including weakness, vision changes, or difficulty speaking.
In rare cases, an AVM can even trigger an ischemic stroke, the type caused by a blocked artery rather than bleeding. One documented case involved a young man with a known AVM who developed sudden paralysis on one side of his body. Imaging showed no hemorrhage, and doctors initially attributed the episode to seizure activity. The actual cause turned out to be an ischemic stroke, and the delay in diagnosis meant he missed the window for clot-dissolving treatment.
Rupture Risk Over Time
The annual risk of an untreated AVM bleeding is roughly 1% to 4% per year. That sounds small in any given year, but it compounds over a lifetime. Because AVMs are typically diagnosed in people around age 30, decades of cumulative risk add up significantly. AVMs that have associated aneurysms on their feeding arteries carry a higher risk, with rupture rates estimated at up to 7% per year.
Lifetime risk calculations typically use a constant annual rate of 2% to 4%. For a 30-year-old, even at the lower end, the probability of a bleed occurring at some point over the following 40 to 50 years becomes substantial.
What Happens When an AVM Bleeds
A ruptured AVM is a medical emergency. The most common first symptom is a sudden, severe headache, often described as the worst headache of a person’s life. Depending on the location, you might also experience seizures, loss of consciousness, weakness or numbness on one side of the body, difficulty speaking, or vision problems.
Survival rates after a first AVM hemorrhage are better than many people expect, though the situation is still serious. About 7% of people who experience a first bleed die within 30 days, and the six-month fatality rate is roughly 12%. For context, ischemic strokes in older adults carry comparable or higher mortality depending on severity. A small percentage of AVM hemorrhages, about 1.2%, cause sudden death before the person reaches a hospital.
Seizures are another significant danger. Among people with AVM-related epileptic seizures, nearly 6% died suddenly from the seizures themselves, not from bleeding. This underscores that AVMs pose risks beyond hemorrhage alone.
How AVMs Are Found
Many AVMs are discovered incidentally during brain imaging done for another reason, like a headache evaluation or after a seizure. Others are found only after they bleed.
The gold standard for confirming and characterizing an AVM is a specialized type of angiography that provides detailed, real-time images of blood flow through the brain’s vessels. This imaging reveals the size and location of the AVM, which arteries feed into it, and how blood drains out. CT angiography and MRI are also used and can show the AVM’s relationship to surrounding brain structures, but they don’t yet match the resolution of the gold-standard test.
Doctors grade AVMs using a scale that accounts for size, location, and drainage pattern. This grading helps determine whether treatment is likely to carry more benefit than risk.
Treatment Options
The goal of treating an AVM is to completely seal off the abnormal tangle of vessels, eliminating the risk of future bleeding. There are three main approaches, and they’re often combined.
- Surgical removal is the most definitive option when the AVM is accessible and not located in a critical area of the brain. It offers immediate elimination of hemorrhage risk once the AVM is fully removed.
- Focused radiation therapy delivers a precise beam of radiation to the AVM, causing the abnormal vessels to gradually thicken and close over a period of months to years. It’s typically used for smaller AVMs (under 3 centimeters) located deep in the brain where surgery would be too risky.
- Embolization involves threading a catheter through blood vessels to the AVM and injecting a substance that blocks blood flow into it. This is often used to shrink the AVM before surgery or radiation rather than as a standalone treatment.
Many cases use a combination of embolization followed by surgery or radiation. Treatment-related fatality rates for unruptured AVMs are low, around 2.5% at six months. Not every AVM requires treatment. Some are monitored over time, particularly when the risks of intervention outweigh the estimated lifetime risk of rupture.
AVM Versus a “Typical” Stroke
Most strokes, about 87%, are ischemic, meaning a clot blocks blood flow to part of the brain. These tend to affect older adults with risk factors like high blood pressure, diabetes, or atrial fibrillation. AVM-related strokes are hemorrhagic, caused by bleeding rather than blockage, and they disproportionately affect younger people who may have no traditional stroke risk factors at all.
The symptoms can overlap significantly. Both types can cause sudden weakness, speech problems, confusion, and severe headache. But the treatment is entirely different. Ischemic strokes are treated by restoring blood flow (dissolving or removing the clot), while hemorrhagic strokes from AVMs require stopping the bleeding and, eventually, addressing the malformation itself. Misidentifying one for the other can lead to dangerous delays, as clot-dissolving drugs given to someone with a brain bleed would make the situation worse.
If you or someone around you develops sudden neurological symptoms, the distinction between AVM bleed and ischemic stroke is something emergency physicians sort out with imaging. What matters in the moment is recognizing stroke symptoms and getting to an emergency room immediately.